Project Grant HT94252510754
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$601K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bar Harbor, ME 04609, USA
Similar Awards
The Defense Health Agency awarded a $754,445 Project Grant to Jackson Laboratory, a nonprofit biomedical research organization, under the Military Medical Research and Development program (CFDA 12.420). The three-year award, effective August 15, 2023 through August 14, 2026, is funding research to target the cGAS-STING axis in order to limit inflammation and neuropathology associated with Gulf War Illness. Jackson Laboratory, located in Bar Harbor, Maine, has extensive experience conducting...
This federal Project Grant award of $276,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Jackson Laboratory in Bar Harbor, Maine. The project aims to develop "whole-brain radiopathomic mapping of glioblastoma infiltration", which will transform healthcare for military service members, veterans, and the broader public by advancing the diagnosis and treatment of this deadly brain cancer. The...
The Defense Health Agency awarded a $1,000,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Jackson Laboratory in Bar Harbor, Maine. The grant will support research to uncover spatial and temporal alterations of metabolism in the kidney, which could pave the way for new treatments for lupus nephritis. The project will be conducted over a 3-year period from May 2025 to May 2028. Jackson Laboratory, a nonprofit biomedical research institution,...
This federal Project Grant award, with a funding amount of $1,893,376.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant aims to "REVEAL SPATIAL TRANSCRIPTOMIC AND PROTEOMIC SHIFTS IN TUMOR-INFILTRATING IMMUNOCYTES: CHARTING A PATH TO ENHANCED MELANOMA THERAPEUTICS" and will be performed by the Jackson Laboratory, a non-profit biomedical research institution located in Bar Harbor, Maine. The grant's...
This $449,000 Project Grant was awarded on September 30, 2024 by the Department of Health and Human Services (CFDA 93.493 - Congressional Directives) to Jackson Laboratory, a non-profit biomedical research institution located in Bar Harbor, Maine. The grant supports the construction or renovation of healthcare facilities, as part of congressionally directed community projects focused on addressing the healthcare needs of underserved populations. Jackson Laboratory has a robust portfolio of...
The Department of Defense's Defense Health Agency awarded a $783,023 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports a 3-year research project titled "A Precision-Medicine Approach to Targeting Acquired Therapeutic Resistance in RTK-Mutated NSCLC". This research aims to transform healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $478,061 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant, with a performance period from September 1, 2024 to August 31, 2026, supports the development of an organoid model for ovarian cancer research and precision medicine. The Henry M. Jackson Foundation, a global non-profit organization, will use this funding to advance...
The Department of Defense's Defense Health Agency has awarded a $1,390,847 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. The grant, with a performance period from September 1, 2025 to August 31, 2028, will support research to investigate the mechanistic role and therapeutic targeting of the cohesin RAD21 protein in metastatic prostate cancer. As a non-profit organization...
The Defense Health Agency awarded a $856,523 project grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on the neurovascular and cognitive recovery from the spectrum of traumatic brain injuries through high-low...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...